Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Innate Pharma - Filing #5981200

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
49 471 EUR
7 570 EUR
Revenue
20 121 EUR
61 641 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
6 896 EUR
32 559 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
9 200 EUR
20 630 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
6 008 EUR
1 966 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.